Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management.
about
Treatment of American tegumentary leishmaniasis in special populations: a summary of evidence.Novel low-cost thermotherapy for cutaneous leishmaniasis in PeruModes of action of Leishmanicidal antimicrobial peptides.Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains.Imported cutaneous leishmaniasis caused by Leishmania major in a Chinese laborer who worked in Saudi Arabia.
P2860
Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cutaneous and mucocutaneous le ...... rogress in disease management.
@en
Cutaneous and mucocutaneous le ...... rogress in disease management.
@nl
type
label
Cutaneous and mucocutaneous le ...... rogress in disease management.
@en
Cutaneous and mucocutaneous le ...... rogress in disease management.
@nl
prefLabel
Cutaneous and mucocutaneous le ...... rogress in disease management.
@en
Cutaneous and mucocutaneous le ...... rogress in disease management.
@nl
P2860
P1476
Cutaneous and mucocutaneous le ...... rogress in disease management.
@en
P2093
Mahreen Ameen
P2860
P304
P356
10.1517/14656560903555219
P407
P577
2010-03-01T00:00:00Z